US Patent 7314890 Sulfonamides
Patent 7314890 was granted and assigned to Allergan, Inc. on January, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+45 characters)
Article
Patent abstract
The present invention provides
Edits on 4 Aug, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
73148900
Date of Patent
January 1, 2008
0Patent Application Number
114264820
Date Filed
June 26, 2006
0Patent Primary Examiner
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07314890 Sulfonamides US Patent 7314890 Sulfonamides
Infobox
Patent Number
0731489000
Patent Number
731489000
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073148900
Date of Patent
January 1, 2008
0Patent Application Number
114264820
Date Filed
June 26, 2006
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073148900
Date of Patent
January 1, 2008
0Patent Application Number
114264820
Date Filed
June 26, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07314890 Sulfonamides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07314890
Date of patent
January 1, 2008
Patent application number
11426482
Date Filed
June 26, 2006
Patent primary examiner
Find more entities like US Patent 7314890 Sulfonamides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
